Alzchem Group AG: Free float rises to 50.35% after placement by LIVIA Corporate Development SE
Trostberg, August 19, 2024 – Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, was informed by LIVIA Corporate Development SE (“LIVIA”) that it sold approx. 2% of its shareholding off-market on Friday, August 16, 2024 and now holds 22.99% of the company. At the same time, LIVIA stated that it currently has no plans to sell any further shares in Alzchem Group AG. Instead, it continues to firmly believe in the growth strategy and the positive business prospects.
Alzchem Group AG views both the increase in the free float to a current 50.35% and LIVIA’s commitment to the company as positive. The successful placement in a very short period of time reflects the high demand for Alzchem shares and should further increase trading liquidity from the company’s point of view.
Contact
Sabine Sieber
Head of Investor Relations & Communications
Alzchem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany
About Alzchem
Alzchem is a globally active specialty chemicals company that is one of the market leaders in most of its fields of activity. Alzchem offers answers to various global developments such as climate change, population growth and increasing life expectancy. We deliver solutions through brands and products of the highest quality and through a sustainable vision to help shape global developments.
The company sees interesting growth prospects for itself in the areas of human and animal nutrition and agriculture in particular. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and creatine products can contribute to a healthy old age as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.
Alzchem Group AG’s broad product range includes dietary supplements, precursors for PCR tests and pharmaceutical raw materials. These offerings are the company’s response to global trends and developments. Alzchem is ideally positioned in this respect and considers itself well prepared for an environmental future and global developments.
The company employs around 1,690 people at four production sites in Germany and a plant in Sweden, as well as three sales companies in the USA, China and England. Alzchem generated Group sales of EUR 540.6 million and EBITDA of EUR 81.4 million in 2023.